Page last updated: 2024-10-24

camostat and Diabetes Mellitus

camostat has been researched along with Diabetes Mellitus in 1 studies

camostat : A benzoate ester resulting from the formal condensation of the carboxy group of 4-guanidinobenzoic acid with the hydroxy group of 2-(dimethylamino)-2-oxoethyl (4-hydroxyphenyl)acetate. It is a potent inhibitor of the human transmembrane protease serine 2 (TMPRSS2) and its mesylate salt is currently under investigation for its effectiveness in COVID-19 patients.

Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ito, T1
Otsuki, M1
Itoi, T1
Shimosegawa, T1
Funakoshi, A1
Shiratori, K1
Naruse, S1
Kuroda, Y1

Other Studies

1 other study available for camostat and Diabetes Mellitus

ArticleYear
Pancreatic diabetes in a follow-up survey of chronic pancreatitis in Japan.
    Journal of gastroenterology, 2007, Volume: 42, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Diabetes Mellitus; Esters; Female; Follow-Up Studies; Gabexate; Guan

2007